Fifth Third Wealth Advisors LLC Sells 11,209 Shares of Procter & Gamble Company (The) $PG

Fifth Third Wealth Advisors LLC reduced its stake in Procter & Gamble Company (The) (NYSE:PG) by 18.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 48,521 shares of the company’s stock after selling 11,209 shares during the period. Fifth Third Wealth Advisors LLC’s holdings in Procter & Gamble were worth $6,953,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in PG. Brighton Jones LLC grew its position in Procter & Gamble by 51.5% during the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock worth $6,717,000 after acquiring an additional 13,617 shares during the last quarter. Taylor Financial Group Inc. increased its holdings in Procter & Gamble by 10.6% in the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock worth $493,000 after purchasing an additional 277 shares in the last quarter. Sivia Capital Partners LLC raised its position in Procter & Gamble by 19.8% in the second quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company’s stock valued at $979,000 after purchasing an additional 1,016 shares during the last quarter. Auxano Advisors LLC boosted its stake in shares of Procter & Gamble by 10.8% during the second quarter. Auxano Advisors LLC now owns 7,315 shares of the company’s stock valued at $1,165,000 after purchasing an additional 714 shares in the last quarter. Finally, Schnieders Capital Management LLC. boosted its stake in shares of Procter & Gamble by 2.8% during the second quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company’s stock valued at $4,809,000 after purchasing an additional 809 shares in the last quarter. 65.77% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on PG shares. BNP Paribas Exane lowered their price objective on Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating for the company in a research note on Friday, January 16th. Dbs Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating in a report on Friday, January 23rd. Jefferies Financial Group upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and upped their price target for the company from $156.00 to $179.00 in a research report on Tuesday, December 16th. TD Cowen downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating and raised their price target for the company from $150.00 to $156.00 in a research note on Tuesday, January 27th. Finally, Barclays set a $155.00 price target on shares of Procter & Gamble in a report on Friday, January 16th. Twelve analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and an average target price of $167.83.

Insider Activity

In related news, insider Moses Victor Javier Aguilar sold 15,169 shares of the company’s stock in a transaction dated Friday, February 13th. The stock was sold at an average price of $162.28, for a total transaction of $2,461,625.32. Following the sale, the insider owned 44,735 shares in the company, valued at $7,259,595.80. This represents a 25.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Susan Street Whaley sold 1,809 shares of the firm’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $159.46, for a total value of $288,463.14. Following the sale, the insider directly owned 30,215 shares of the company’s stock, valued at $4,818,083.90. This represents a 5.65% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 348,618 shares of company stock worth $55,462,643. 0.20% of the stock is owned by insiders.

Procter & Gamble Stock Down 0.2%

Procter & Gamble stock opened at $144.44 on Wednesday. The firm has a market cap of $335.67 billion, a price-to-earnings ratio of 21.40, a PEG ratio of 4.84 and a beta of 0.37. Procter & Gamble Company has a 52-week low of $137.62 and a 52-week high of $174.80. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72. The firm has a 50 day moving average price of $153.88 and a two-hundred day moving average price of $149.88.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Friday, January 23rd. The company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.86 by $0.02. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The company had revenue of $22.21 billion for the quarter, compared to analyst estimates of $22.36 billion. During the same period in the prior year, the firm posted $1.88 EPS. The company’s quarterly revenue was up 1.5% on a year-over-year basis. Equities analysts predict that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, February 17th. Shareholders of record on Friday, January 23rd were given a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, January 23rd. This represents a $4.23 dividend on an annualized basis and a yield of 2.9%. Procter & Gamble’s dividend payout ratio is 62.52%.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: OLAY peptide research — New clinical and mechanistic data presented for OLAY highlight proprietary peptide technology and cell‑adhesion targets that P&G plans to move rapidly into formulations; successful commercialization could bolster pricing power and organic growth for a core beauty brand. OLAY Peptide Research Puts New Spotlight On Procter And Gamble Valuation
• Positive Sentiment: Analysts remain constructive in places — coverage notes that P&G can fare better than peers amid sluggish consumer sentiment, supporting the view of PG as a relatively defensive consumer staples holding. Analysts Constructive on The Procter & Gamble (PG) Amid Sluggish Consumer Sentiment
• Neutral Sentiment: Recent trading strength — PG ticked higher while the broader market fell on 3/30, showing relative strength that may reflect defensive demand; however this was a short‑term move rather than new fundamental news. Procter & Gamble (PG) Ascends While Market Falls: Some Facts to Note
• Neutral Sentiment: Q4 results mixed — Q4 EPS slightly beat estimates (+$0.02) while revenue marginally missed; steady margins and cash flow help the case for the dividend and buybacks, but top‑line softness tempers upside. (Earnings detail from recent company report.)
• Neutral Sentiment: Deutsche Bank trimmed its price target (from $171 to $162) but kept a Hold — this narrows upside but is not a sell signal; investors should weigh this against other analyst views. Deutsche Bank Lowers Price Target on PG
• Neutral Sentiment: Unrelated retailer weakness — a separate report on RH’s weak quarter is unlikely to directly affect PG but signals broader discretionary‑spending challenges in retail. RH (RH) Lags Q4 Earnings and Revenue Estimates
• Negative Sentiment: TD Cowen cut its price target to $142 (from $156) and kept a Hold, citing oil‑linked input cost inflation tied to the Iran war that it believes P&G cannot fully absorb — this is the main near‑term headwind pressuring the stock. Wall Street Downgrades Procter & Gamble Amid Iran War Cost Pressures and More

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.